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Tretinoin is used in the management of acne and it is part of a gold standard treatment for photoaging. It 
has also been reported as an agent for superficial chemical peeling in highly concentrated formulations 
with few considerations about skin penetration. The aim of this study was to evaluate the influence of 
drug concentration and vehicles currently used on skin penetration of tretinoin. In vitro permeation tests 
were carried out using Franz diffusion cells fitted with porcine ear skin and 10% aqueous methanol in the 
receptor compartment. Formulations studied, cream or hydroalcoholic dispersion, containing 0.25%, 1% 
and 5% of tretinoin were placed in the donor compartment for six hours. Tretinoin concentration in skin 
layers was measured by high performance liquid chromatography. The largest amount of tretinoin from 
both vehicles was detected in stratum corneum with significant differences among the three concentrations. 
The hydroalcoholic dispersion was the best vehicle. Significant amounts of tretinoin were found even in 
deep layers of epidermis. The formulation with 0.25% tretinoin showed better results when considered the 
amount of tretinoin on skin in terms of percentage. Finally, skin penetration of tretinoin was influenced 
by vehicle and concentration of this drug used in formulation.
Uniterms: Tretinoin/skin penetration/in vitro study. Chemical peeling. Topical formulations/analysis.
A tretinoína é usada no tratamento de acne e é considerada como padrão de ouro para o tratamento do 
fotoenvelhecimento. Em altas concentrações, é relatada como um agente para peeling químico superficial, 
com poucas considerações sobre a penetração na pele. O objetivo deste estudo foi avaliar a influência da 
concentração do fármaco e os veículos comumente usados na penetração cutânea da tretinoína. Testes in 
vitro de penetração foram realizados com células de difusão de Franz equipados com pele da orelha de 
porco e 10% de solução aquosa de metanol no compartimento receptor. As formulações estudadas, creme 
ou dispersão hidroalcoólica, contendo 0,25%, 1% e 5% de tretinoína foram colocadas no compartimento 
doador, durante seis horas. A concentração da tretinoína foi medida por cromatografia líquida de alta 
eficiência. A maior quantidade de tretinoína foi detectada no estrato córneo com diferenças significativas 
entre as três concentrações. A dispersão hidroalcoólica foi o melhor veículo. Quantidades significativas de 
tretinoína foram encontradas nas camadas profundas da epiderme. A formulação com 0,25% de tretinoína 
mostrou melhores resultados em termos de porcentagem penetrada na pele. Por fim, a penetração de 
tretinoína na pele foi influenciada pelo veículo e pela concentração desta utilizada na formulação.
Unitermos: Tretinoína/penetração na pele/estudo in vitro. Peeling químico. Formulações tópicas/análise.
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INTRODUCTION
Tretinoin (TRE) or all-trans-retinoic acid (RA) 
is indicated for treatment of acne vulgaris, melasma, 
photoaging, follicular keratosis, striae and disorders 
of keratinization (Thiboutot, Gollmick, 2009). It is 
well known that retinoids act by binding to specific 
nuclear receptors, interfering in gene expression and 
affecting cellular proliferation and differentiation, sebum 
production, inflammation, immunological reactions 
and possibly in non-melanoma skin cancer prevention 
(Stratigos, Katsambas, 2005).
The nuclear retinoic acid receptor family (RARs 
e RXR) is activated by TRE. By interaction with RARs 
and RXR, TRE executes its effect by one or more 
mechanism(s): a) epidermal thickening due to initiation 
of epidermal proliferation; b) compaction of the stratum 
corneum; and c) biosynthesis and deposition of the 
glycosoaminoglycans and collagen (Raza et al., 2013).
Since the 80`s it has been demonstrated that 
continuous use of 0.025%, 0.05% or 0.1% TRE cream 
may repair clinical and histological signs of photoaging 
(Kligman, Duo, Kligman, 1984; Samuel et al., 2005; Ting, 
2010). Higher drug concentrations (1% to 5%) have been 
proposed as peeling agents in adjuvant treatments of slight 
and moderate photoaging, melasma and poikiloderma (Cucé 
et al., 2001; Khunger, Sarkar, Jain, 2004; Landau, 2008).
Chemical peelings consist of topical applications 
of caustic substances, which result in the loss and 
regeneration of superficial skin layers. Classical agents 
are: Jessner’ solution, 70% glycolic acid, 30% salicylic 
acid and 10 to 35% tricloroacetic acid. Their use is 
indicated as adjuvant treatments for various dermatosis 
such as photoaging, acne, melasma, hyperpigmentations, 
scars among others (Roy, 2005). Sequential superficial 
chemical peelings may result in epidermis and papillary 
dermis reorganization (Imayama, Ueda, Isoda, 2000).
The application of high concentration TRE 
formulations at the beginning of treatment in self usage 
or in sequential superficial peelings could be useful to 
produce retinoid benefits in a shorter period of time. 
However, to obtain these benefits it is necessary that 
topical drugs penetrate through follicular and sweat 
openings, intercellular spaces, stratum corneum (SC) or 
keratinocytes (Wester, Maibach, 1994). Human skin is a 
highly effective barrier against penetration of chemical 
and other agents. Thus, skin penetration depends on SC 
thickness, integrity and lipid composition, number of 
follicular openings, drug concentration and formulation 
vehicle (Manconi et al., 2006; Contrera et al., 2005).
For this, various in vivo and in vitro methods have 
been proposed to evaluate skin penetration. Among these 
methods, we used the Franz cell method to shed some 
light on the possible mechanism of skin penetration by 
formulations under study.
Considering that skin penetration could influence 
the cutaneous effects of the tretinoin-based formulations, 
the aim of this study was to evaluate the skin penetration 
of TRE vehiculated in two vehicles currently used as in 
three different concentrations.
MATERIAL AND METHODS
Material
All material used in this study were obtained from 
Galena (São Paulo, Brazil). Different TRE concentrations 
(0.25%, 1%, and 5%) were used as cream (stable emulsion 
composed of cetearyl alcohol, sodium cetearyl sulfate, 
decyl oleate, phenoxyethanol, parabens, glycerin and 
distilled water) and as hydroalcoholic dispersion (equal 
parts of distilled water and ethanol). The experimental skin 
was porcine ear and analytical grade 10% methanol was 
used in the receptor compartment of the Franz diffusion 
cell (HPLC grade, Sigma-Aldrich, Germany).
Penetration tests in vitro
The receptor chamber of a Franz diffusion cell 
(Microette-Hanson Research, Chatsworth, CA, USA) was 
composed of six individual cells with porcine skin placed 
with dermis facing the methanol solution and 400 mg of 
TRE formulations were placed in the donor chamber. The 
entire system was kept at 37 ± 0.5 °C in a thermostated 
bath during the permeation test (6 hours). Removed skin 
samples were rinsed to eliminate excess formulation and 
fixed. The SC was separated from epidermis and dermis by 
14 repeated tape strippings using adhesive strips (Scotch 
Book Tape, n.845; 3M, St. Paul, MN, USA). TRE in 
stripings and skin layers was extracted by 10% aqueous 
methanol and quantified by Bonhomme (1990) method 
in High Performance Liquid Chromatography (HPLC) 
as were the contents of the receptor chambers (SPD-10A, 
equipped with VIS-UV detector operating at 343 nm). 
TRE concentrations in SC and epidermis + dermis 
represent topical delivery, whereas transdermal delivery is 
defined by the amounts detected in the receptor chamber.
Validation of the analytical method
A dose equivalent to 5 mg of TRE was dissolved in 
5 mL of methanol (1 mg/mL). Aliquots were diluted in 
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methanol to obtain the following concentrations: 5, 10, 
20, 25, 50, 60, 75 and 100 μg/mL, which were analyzed 
in triplicate by HPLC-UV (Bonhomme, 1990); results 
were inserted into a graph with three curves. The medium 
curve was in accordance to Brazilian Regulatory Agency 
(Agência Nacional de Vigilância Sanitária, ANVISA, 
Brazil). Linearity was evaluated through the coefficient 
of variation of replicate points and the coefficient of 
linear correlation (r2). Accuracy was assessed by the 
coefficient of variation in determinations at each point of 
the calibration curve in triplicate during three consecutive 
days (inter-day) as well as in three points 10 times in one 
day (intra-day). Precision was calculated by variation 
between expected and observed concentrations at each 
point of the calibration curve when solutions were 
analyzed in triplicate for three consecutive days (inter-day) 
and 10 times in one day (intra-day).
Statistical analysis
Data analysis was carried out with the software 
OriginPro 7.0 (OriginLab Corporation, USA). Results 
are expressed by means ± standard deviation. Multiple 
comparisons of means (Tukey test) were used to 
substantiate statistical differences among each sample 
and skin layer (stratum corneum and epidermis + dermis). 
Significance was tested at the 0.01 level of probability (p). 
The results for different vehicles were analyzed separately, 
i.e., one ANOVA for each of the two used considering 
three TRE concentrations (0.25, 1 and 5%). Data variation 
analysis was performed in a completely randomized 
design, considering two experiments analyzed separately 
(two vehicles), composed of three treatments (0.25, 1 and 
5% TRE concentrations in the sample) x 4 replications per 
treatment x 2 skin layer.
RESULTS
In the present experimental study, the skin 
penetration of six different formulations was tested. The in 
vitro topical and transdermal drug delivery was evaluated 
by the Franz diffusion cell test, a standard method for 
these procedures (Manconi et al., 2006). TRE amounts 
in skin layers and receptor chamber were quantified by 
HPLC, which was used under strict conditions to separate 
all-trans from 13-cis retinoic acid and other impurities as 
it had already been recommended (Manconi et al., 2006). 
Separation of trans isomer was satisfactory but over 
the time a slight degradation of TRE produced another 
compound, which was not identified.
The linear correlation coefficient determined in the 
TRE standard curve analysis by HPLC-UV was 0.998 
which complied with limits established by ANVISA, 
Brazil, i.e., ≥ 0.9932. Accuracy and precision values 
showed coefficients of variation ≤ 4%.
The greatest amounts of TRE were retained in SC 
regardless of the concentration in cream formulations. 
However, it was significantly higher when the 5% 
concentration was used (p<0.01). The average amounts of 
TRE delivered into epidermis + dermis was not significantly 
different for 0.25%, 1% and 5% concentrations (Table I).
The amount of TRE, which permeated epidermis + 
dermis and reached the receptor compartment was lower 
than the method quantification limit.
The average amounts of TRE in hydroalcoholic 
dispersion retained in skin layers was significantly 
different (p<0.01) and much higher in SC than epidermis 
+ dermis when comparing the three concentrations of drug 
used (Table II).
Comparing vehicles with the same concentrations 
of TRE the hydroalcoholic dispersion allowed higher 
penetration (Figure 1).
The cost-to-benefit ratio of each formulation was 
calculated in terms of percentage. The amount of tretinoin 
in each skin layer was divided by the total amount of 
tretinoin in each formulation. The results were expressed 
as a percentage of the total amount in the formulation. 
Among cream formulations, 0.25% showed the best 
relation in stratum corneum and epidermis + dermis 
(Figure 1). However, for hydroalcoholic dispersions, 
0.25% TRE formulation showed only the best cost-to-
benefit ratio in epidermis + dermis (Figure 1).
TABLE I - Tretinoin average concentrations retained in skin layers (μg/cm2) for the three cream formulations
Tretinoin concentration in cream 
formulations(%)
Tretinoin retained in the stratum 
corneum (μg/cm2)
Tretinoin retained in the epidermis + 
dermis (μg/cm2)
0.25 17.37 ± 3.79 B 8.42 ± 1.28 A
1 16.39 ± 6.74 B 7.66 ± 3.97 A
5 53.96 ± 9.37 A 14.26 ± 4.93A
*Means followed by the same letter are not statiscally different (p<0.01).
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DISCUSSION
The first  proposal  about the use of highly 
concentrated TRE as an agent for superficial peeling was 
reported by a Brazilian group in 2001 (Cucé et al., 2001). 
The authors sequencially used 1, 2, 3, 4 and 5% TRE 
concentrations in a solution with equal parts of ethanol 
and propilenoglycol. They suggested two applications per 
week, in five sessions and reported no discomfort other 
that the remaining solution should be washed out after 6 to 
12 hours, at home. One year later, they recommended the 
use of 5% TRE peeling, once a week, in three applications 
(Cucé, Bertino, 2002). At that time, a letter was sent to the 
journal questioning stability and the advantage of such a 
high concentration (Kligman, 2001).
Retinoids are the most effective comedolytic 
agents. They provide multiple benefits for acne treatment 
such as: normalizing desquamation of the follicular 
epithelium, preventing formation of new microcomedo 
and minimizing the formation of comedones and 
inflammatory lesions (Manela-Azulay, Bagatin, 2009). 
However, they cause irritative dermatitis during the 
early phase of skin retinization, which may lead to 
discontinuation of treatment (Kang et al., 2005). Thus, 
considering that the tretinoin penetration on the skin could 
influence the efficacy of the tretinoin-based formulation, 
this study can contribute for the definition of the best TRE 
concentration and vehicle in order to obtain the best results 
and a rational use of this active ingredient, as well as, avoid 
undesirable effects.
The skin is the largest organ and, as our primary 
external barrier, it is on the forefront of the battle with 
external causes of damaging free radicals. The most 
significant damage by free radicals is to biomembranes 
and to DNA. It is thought that topical use of vitamins and 
antioxidants in cosmetics and skin care products can better 
protect and possibly correct the damage by neutralizing 
these free radicals. In addition, some vitamins may be 
beneficial to the skin because of other actions such as 
suppression of pigmentation and bruising, stimulation 
of collagen production, refinement of keratinization, or 
anti-inflammatory effects (Lupo, 2001). In this sense, the 
highest amount of TRE found in stratum corneum likely 
indicates the effectiveness of TRE just for exfoliation.
The influence of concentration and vehicle in 
retinol formulation stability and skin penetration has 
already been demonstrated in vitro (Gomes, Gaspar, 
Maia Campos, 2007; Bagatin et al., 2010). The search 
for an acceptable delivery system for all-trans retinoic 
acid with no risk of systemic absorption and side effects, 
using mice abdominal skin as an experimental model, 
demonstrated that the encapsulated form (multilamellar 
large vesicles) promoted retention on skin superficial 
layers and prolonged drug release (Gomes, Gaspar, Maia 
Campos, 2007).
Skin penetration of vitamin A (retinol) in two 
vehicles, self-nanoemulsifying system and classic gel 
cream, using Franz cells method was evaluated (Gianetti 
et al., 2012) The authors found that both formulations 
presented the same particle size and the gel cream classic 
formulation furnished better penetration in both stratum 
corneum and epidermis + dermis.
TABLE II - Tretinoin average concentrations retained in skin layers (μg/cm2) for the three hydroalcoholic formulations
Tretinoin concentration in 
hydroalcoholic formulations(%)
Tretinoin retained in the stratum 
corneum(μg/cm2)
Tretinoin retained in the epidermis + 
dermis (μg/cm2)
0.25 76.26 ± 19.14 C 8.43 ± 2.39 C
1 276.24 ± 67.87 B 13.57 ± 5.09 B
5 2074 ± 651.13 A 119.83 ± 26.06 A
*Means followed by the same letter are not statiscally different (p<0.01).
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FIGURE 1 - Percentages of TRE in skin layers delivered from 
three concentrations of the drug in cream and hydroalcoholic 
dispersion formulations.
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Concerning to drug delivery, it is essential that the 
drug pass the skin barrier (stratum corneum) to reach the 
living cells (Mak et al., 2011). Thus, we can speculate 
that the low percentage of tretinoin that penetrated 
the epidermis and the risk of side effects of high TRE 
concentration suggest limited advantage of its use as agent 
for chemical peeling, except if the desirable result is just 
an exfoliation.
To be effective in acne and photoaging treatments, 
TRE must cross the SC and reach deeper layers 
where it may reduce sebum production and follicular 
hyperkeratinization as well as increase collagen synthesis 
by binding to specific receptors (Draelos, Ertel, Berge, 
2006; Bellemère, 2009).
The tested formulations may be considered effective 
since the percentage of TRE deposited in skin layers was 
more than 18% in some samples (5% hydroalcoholic 
dispersion). A novel class of lipossomes to promote dermal 
delivery of TRE was developed and authors observed, as 
the highest percentage of penetration in porcine skin after 
8 hours, no more than 12% (Manconi et al., 2011).
A recent study about TRE skin penetration 
demonstrated that an ethanol solution presented the best 
drug penetration profile. After 6 hours of application, 
around 50% of TRE had permeated mice skin (Raza et 
al., 2013).
The rapid retinization of photoaged facial skin by 
daily topical application of 0.25% TRE had already been 
suggested (Kligman, Draelos, 2004).
Under experimental conditions, 0.25% TRE cream 
formulation showed high cost-to-benefit ratio mainly when 
compared to the cream formulations with four (1%) and, 
twenty (5%) times of this active ingredient. Additionally, 
cream vehicles could reduce the irritation caused by TRE. 
Thus, a rapid retinization of skin without pronounced 
side effects could be achieved using a more rational TRE 
concentration and a suitable vehicle.
Finally, the present study highlights the importance 
of vehicle and TRE concentration on skin penetration to 
achieve desire effects and avoid common problems like 
skin irritation, erythema and desquamation.
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